A groundbreaking national survey reveals cannabinoid hyperemesis syndrome prevalence affects nearly 1 in 5 daily cannabis users. This first population-level study provides critical data for clinicians treating cannabis-related health issues. The findings suggest CHS represents a significant public health concern requiring systematic clinical attention.
[Management of cannabinoid hyperemesis syndrome].
A clinical review confirms that cannabinoid hyperemesis syndrome prevalence reaches approximately one-third of regular cannabis users. The condition presents with characteristic recurrent vomiting episodes and the distinctive finding of temporary relief with hot water exposure, making it an important consideration for clinicians managing cannabis patients.
New side effect from smoking cannabis discovered in groundbreaking study – LADbible
✦ New CED Clinical Relevance #72 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchNeurologyAgingSafety Why This Matters This finding is clinically significant because it expands understanding of cannabis...
If you’re wondering what you should have for dinner tonight, I have an idea…
The munchies remain cannabis's most reliable and least pharmacologically sophisticated side effect, though it does demonstrate robust cannabinoid-endocannabinoid system engagement in appetite regulation. Your refrigerator's contents are about to undergo comprehensive clinical...
THC Panic Symptoms: Why Weed Can Feel Like Panic
THC panic symptoms often begin in the body before they become a fearful thought. This blog explains how cannabis can increase heart rate, intensify body awareness, and trigger a spiral of misread alarm signals, especially in newer or more anxiety-sensitive users.
Preclinical evidence of cannabis-induced oxidative stress: A systematic review and meta-analysis.
Although cannabis exposure is linked to oxidative stress, no systematic analysis has evaluated its effects on ROS production, lipid peroxidation, and antioxi…
Spontaneous Pneumomediastinum and Cannabinoid Hyperemesis Syndrome: A Case Report and Literature Review.
We report the case of an 18-year-old man with a six-month history of chronic marijuana use who developed spontaneous pneumomediastinum (SPM) following multip…
Alcohol as a Novel Trigger for Cannabis Hyperemesis Syndrome.
Cannabis hyperemesis syndrome (CHS) is a paradoxical condition occurring in chronic cannabis users, characterized by cyclic nausea, vomiting, and abdominal p…
Cannabis hyperemesis syndrome cases surge in Virginia ERs – YouTube
WHY IT MATTERS: If you use cannabis regularly and experience recurring nausea, vomiting, or abdominal pain that temporarily improves with hot showers, you should talk to your cannabis clinician about adjusting your dose, frequency, or product potency before your next ER visit. CLINICAL OVERVIEW: Cannabis hyperemesis syndrome (CHS) is a real clinical condition characterized by cyclical vomiting, nausea, and abdominal pain in frequent cannabis users, and emergency departments across legalized states are reporting increased presentations. While CHS can be distressing and even dangerous if dehydration becomes severe, it is almost always associated with very high-frequency, high-potency use and resolves reliably with cessation or significant dose reduction.
Cannabis and Dementia Risk: The Truth Behind the Scary Headline
A new study links cannabis-related ER visits to higher dementia risk—but the findings are more about hospital crises than cannabinoids. It’s not about everyday users, and it doesn’t prove causation. Here’s what this paper really tells us—and what it doesn’t.